rss
Thorax 2001;56:394-397 doi:10.1136/thorax.56.5.394
  • Short paper

Enhanced inhibition of lymphocyte activation byMycobacterium avium complex in human T lymphotrophic virus type I carriers

  1. W Matsuyamaa,
  2. R Kubotaa,
  3. T Hamasakib,
  4. A Mizoguchib,
  5. F Iwamib,
  6. J Wakimotob,
  7. M Kawabataa,
  8. M Osamea
  1. aThird Department of Internal Medicine, Kagoshima University School of Medicine, Sakuragaoka 8-35-1, Kagoshima 890-8520, Japan, bDepartment of Respiratory Medicine, National Minami-kyushu Hospital, Kajiki-cho Kida 1882, Aira-gun, Kagoshima 899-5293, Japan
  1. Dr W Matsuyamavega{at}xa2.so-net.ne.jp
  • Received 27 June 2000
  • Revision requested 21 September 2000
  • Revised 21 October 2000
  • Accepted 19 December 2000

Abstract

BACKGROUND We have previously reported that disseminated pulmonaryMycobacterium avium complex (MAC) infection is more common in human T lymphotrophic virus type I (HTLV-I) carriers than in non-carriers. However, the reason for this remains unclear. It has been shown that glycopeptidelipid (GPL), one of the lipid components of the cell envelope of MAC, is able to reduce the lymphocyte blastogenic response to mitogens. The purpose of this study was to clarify whether or not the inhibitory effect of GPL differs between HTLV-I carriers and non-carriers.

METHODS Peripheral blood lymphocytes were obtained from 29 patients who had recovered from pulmonary MAC infection (10 of whom also had HTLV-I infection) and the lymphocyte counts and T cell subpopulations of the peripheral blood lymphocytes in HTLV-I carriers and non-carriers were compared. The inhibitory effect of GPL on the lymphocyte blastogenic response to phytohaemagglutinin (PHA) was tested in these 29 cases and in 15 healthy controls who had never suffered from MAC (seven of whom also had HTLV-I infection). All HTLV-I positive cases were carriers.

RESULTS There was no significant difference in the numbers or subset proportions of T cells between HTLV-I carriers and non-carriers. Lymphocyte activation by PHA was significantly inhibited by GPL in MAC positive and negative HTLV-I carriers compared with MAC negative non-carriers and MAC negative healthy controls (p<0.001).

CONCLUSIONS We suggest that MAC infection leads to strong inhibition of lymphocyte activation in HTLV-I carriers. This may account, in part, for the severity of pulmonary MAC infection in HTLV-I carriers.

Footnotes

  • This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research (OPSR) Japan.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.